Low density lipoprotein (LDL) conditioned by incubation in the presence of rabbit aortic or human umbilical vein endothelial cells (endothelial cell-modified LDL) was degraded by macrophages three to five times more rapidly than LDL incubated in the absence of cells (control LDL). This enhanced degradation occurred mostly via a high affinity, saturable pathway related to the pathway for macrophage uptake of acetylated LDL. Conditioning LDL with cultured aortic smooth muscle cells had a qualitatively similar but smaller effect; conditioning with fibroblasts had no effect. Conditioning very low density lipoproteins or high density lipoproteins with endothelial cells did not affect subsequent metabolism of these lipoproteins by macrophages. Endothelial cell-modified LDL, while degraded more rapidly than control LDL by macrophages, was degraded more slowly by cultured smooth muscle cells and by human skin fibroblasts. Degradation of endothelial cell-modified LDL by macrophages was accompanied by stimulation of cholesterol esterification, inhibition of cholesterol synthesis, and a net increment in total cellular cholesterol content. Thus, a biologically generated modification of LDL is described that markedly alters cholesterol metabolism of macrophages and, consequently, may play a role in foam cell formation during atherogenesis. (Arteriosclerosis 3
T he biological mechanisms leading to the formation of foam cells in atherosclerotic lesions have yet to be clarified. It is generally accepted that a significant fraction of foam cells is derived from cells of the mononuclear phagocyte system, 1 -3 and that the major portion of the cholesterol in atheromata is derived from plasma LDL. Yet, paradoxically, the capacity of macrophages to take up native LDL is relatively low, 4 suggesting the possibility that not LDL itself but some modified form of it is actually responsible for the delivery of cholesterol to the macrophage. Several chemically modified forms of LDL (acetylated LDL, 4 acetoacetylated LDL, 5 and malondialdehyde-conjugated LDL 6 ) are taken up by macrophages several times faster than is native LDL.
There has, however, been no evidence for the occurrence of such chemically modified forms in vivo nor any evidence that they can be formed biologically. It has been reported that some malondialdehyde-conjugated LDL is formed in vitro from LDL during platelet aggregation. 6 We have previously reported that conditioning of human LDL with cultured rabbit aortic endothelial cells converts it to a form that is taken up and degraded by murine macrophages at rates three to five times the rate for control LDL. 7 The LDL conditioned by prior incubation with endothelial cells (endothelial cell-modified LDL; EC-modified LDL) was taken up by macrophages and degraded via a high affinity, saturable pathway related at least in part to the pathway for uptake of acetylated LDL. 7 The present studies show for the first time that EC-modified LDL can be produced using human umbilical vein endothelial cells. The effects of EC-modified LDL on macrophage cholesterol metabolism are demonstrated and the physical properties of EC-modified LDL are described. The effects of conditioning very low density lipoproteins and high density lipoproteins with endothelial cells are compared with the properties expressed by EC-modified LDL. Finally, it is demonstrated that LDL conditioned by incubation with smooth muscle cells is also more rapidly degraded by macrophages. A preliminary report of some of these studies has been presented. 8 
Methods

Materials
Dulbecco's Modified Eagle's Medium, Ham's F-10 Medium, and alpha Minimal Essential Medium (a-MEM) were purchased from Grand Island Biological Company (GIBCO), Berkeley, California. Fetal calf serum was obtained from Hy-Clone Sterile System, Incorporated, Logan, Utah, and calf serum and newborn calf serum, from Irvine Scientific, Santa Ana, California. Culture dishes were obtained from Lux Scientific Corporation, Newbury Park, California. Swiss Webster mice were obtained from Simonsen Laboratories, Gilroy, California. Special enzyme grade sucrose was obtained from Schwartz-Mann, Division of Becton, Dickinson and Company, Orangeburg, New York. Cholesterol ester hydrolase and cholesterol oxidase were purchased from Boehringer-Mannheim, West Germany. Carrier-free sodium 12S l-iodide and l- 14 
Cells
We used rabbit aortic endothelial cells from an established line provided by Vincenzo Buonassisi, Department of Biology, University of California, San Diego. These cells have been shown to exhibit most of the characteristic properties of endothelial cells 9 and previous studies have demonstrated that they express high affinity LDL receptors. 10 Normal human umbilical vein endothelial cells were isolated and cultured in F-10 medium containing 15% fetal calf serum as described elsewhere, 11 ' 12 and used as primary cultures within 12 days of plating. A strain of bovine aortic endothelial cells (11 -BAEC) was a generous gift of Michael A. Gimbrone, Department of Pathology, Harvard University. Cultures of smooth muscle cells derived from swine and guinea pig aortas were initiated according to established techniques 13 and grown in Dulbecco's Minimal Essential Medium supplemented with 10% fetal calf serum. The identity of these cells as smooth muscle cells was confirmed by electron microscopy. 13 Normal human skin fibroblasts were obtained and cultured in Dulbecco's Minimal Essential Medium containing 10% calf serum as described. 14 An established macrophage cell line, J774 cells, were provided by Jay Unkeless and Helen Plutner, The Rockefeller University, New York, New York, and were maintained in suspension culture in a-MEM supplemented with 5% newborn calf serum. Experiments were carried out using monolayer cultures seeded 2 days previously at 1.5 x 10 5 cells per 35-mn dish and grown in the same medium. Resident peritoneal macrophages were harvested from Swiss Webster mice by peritoneal lavage 15 using Ca 2+ -, Mg 2+ -free phos-phate buffered saline and plated in 60-mm culture dishes at 2 x 10 7 cells/dish in a-MEM supplemented with 10% fetal calf serum.
Llpoprotelns
Normal human serum lipoproteins were prepared as previously described. 14 Low density lipoproteins (LDL) were isolated in the density range 1.019-1.063, high density lipoproteins (HDL) in the range 1.063-1.21, and very low density lipoproteins (VLDL) at a density less than 1.006. The lipoproteins were radioiodinated using a modification 14 of the method of McFariane. 16 The range of specific activities was 120-250 cpm/ng. The amount of radioactivity associated with lipids in the radiolabeled LDL was less than 3% of the total trichloroacetic acid-precipitable radioactivity.
Endothelial Cell-Modified LDL
Monolayers (60-mm dishes) of endothelial cells were refed with fresh F-10 medium containing 15% fetal calf serum. After 24 hours the monolayers were washed four times with serum-free F-10 medium and then incubated with 2 ml of serum-free F-10 medium containing radiolabeled or unlabeled LDL (200 /ig protein/ml unless otherwise specified). After the indicated times of incubation, the medium was collected under sterile conditions and centrifuged for 15 minutes at 1000 x gto remove any cell remnants. The supernate was stored under sterile conditions at 4°C. This LDL, conditioned by exposure to endothelial cells, is referred to as EC-modified LDL. The same procedures were used in studies where LDL was conditioned by exposure to other cell types, e.g., smooth muscle cell-conditioned LDL.
Control Lipoproteins
These were prepared by incubating them in the absence of cells but otherwise following the same protocol used to prepare cell-conditioned lipoproteins. The dishes used were preincubated with 15% fetal calf serum in F-10 medium for at least 20 hours and washed four times before use.
Acetylated LDL
Acetylated LDL was prepared as described by Basu et al. 17 
Degradation Studies
To measure degradation of lipoproteins in macrophages, monolayers of J774 cells were washed twice with F-10 medium and then incubated with F-10 medium containing cell-conditioned or control 12S l-labeled lipoproteins at indicated concentrations. At the end of the incubation, the medium was removed and assayed for acid-soluble, noniodide 125 I degradation products as described. 7 Cells were washed four times with phosphate-buffered saline (PBS), dissolved in 0.25N NaOH, and aliquots were assayed for protein. 18 The same procedure was used for determining degradation of 12S I-LDL in smooth muscle cells or fibroblasts.
Unless otherwise indicated, the conditioned and control 125 I-LDL preparations were directly transferred in the appropriate dilution to macrophage cultures in which degradation rates were to be measured and to parallel cell-free dishes as in the preliminary experiments reported elsewhere. 7 The amount of degradation products measured in the medium of the cell-free incubations (which included degradation products generated during the prior incubation with endothelial cells) was subtracted from that obtained in corresponding dishes containing cells. To rule out the possibility that materials released from the conditioning cells might alter the metabolic behavior of the LDL or influence the metabolism of the degrading cells, LDL in some experiments was reisolated after conditioning using either sucrose gradient ultracentrifugation 7 or flotation in KBr (density 1.123 g/ml, 160,000 x g for 48-72 hours ), and dialyzed against PBS (pH 7.4) containing 0.01% EDTA. In these experiments, control LDL prepared in cell-free dishes was reisolated in the same manner.
Assays
Cell monolayers to be extracted for lipid determinations were first rinsed four times with PBS, scraped with a rubber policeman, and centrifuged (200 x g, 10 minutes). The cell pellet was then sonicated in 0.5-1.0 ml water. Separate aliquots were removed from the suspension for protein determination 18 and lipid extraction. 19 Acyl-CoA:cholesterol acyltransferase activity was assayed by measuring 3 H-oleate incorporation into cholesteryl esters as described. 20 Lipid extracts of lipoproteins were prepared as described. 19 Total and free cholesterol in lipid extracts of macrophages were quantitated using the ferric chloride 21 or enzymatic 22 method. Determination of malondialdehyde content of LDL was done as described by Fogelman et al. 6 Electrophoresis of LDL was performed as described elsewhere. 23 The density distribution of LDL was determined using sucrose-gradient ultracentrifugation as described previously. 7 Briefly, the culture medium containing the LDL preparations was layered either at the top or at the bottom of a discontinuous sucrose gradient, after 48to 64 hours centrifugation at 170,000 x gat 12°C, the contents of the tubes were fractionated and the density and LDL content of each fraction were determined.
Results
Human LDL conditioned in the presence of rabbit endothelial cells was degraded by macrophages more rapidly than LDL preincubated in the absence of cells ( Figure 1 ). The rate of macrophage degrada- hours. The media were collected and diluted with F-10 medium to obtain a final LDL concentration of 10 pig protein/ml. Aliquots of these diluted media were added to cultures of J774 macrophages which were then incubated for the indicated time periods. The amount of 125 I-LDL degradation products was determined in medium samples harvested at each time point (see Methods section). Each value represents the mean of duplicate incubations; the range was less than ± 10%. tion of EC-modified LDL and of control LDL was approximately constant for 20 hours. In subsequent studies, the effects of modification on lipoprotein degradation were evaluated in macrophages using 5-hour incubation periods. In the example shown in Figure 1 , EC-modified LDL was degraded about three to four times more rapidly than control LDL. The magnitude of the change in rate of macrophage degradation of EC-modified LDL depended upon the length of time native LDL was incubated in the endothelial cell cultures. An increase was apparent as early as 3 to 8 hours and the effect became more striking with longer conditioning periods, being directly proportional to time after the initial lag phase ( Figure 2) .
INCUBATION WITH MACROPHAGES (h)
The time-dependent increase in the rate of macrophage metabolism of EC-modified LDL depicted in Figure 2 was accompanied by time-dependent changes in the electrophoretic mobility and buoyant density of the same lipoprotein preparation. An increase in the electrophoretic migration of EC-modi- tied LDL was first detected within 6 to 9 hours of conditioning and became progressively greater until it reached a plateau at 24 hours. Control LDL exhibited the same mobility as native LDL. The buoyant density of EC-modified LDL increased linearly from 1.034 to 1.060 between 0 and 24 hours of conditioning, whereas the buoyant density of control LDL did not change, as previously reported. 7 In a separate experiment illustrated in Figure 3 , a density shift from 1.036 to 1.078 occurred during a 24-hour conditioning period. Density increased significantly by 8 hours, before there was any evident change in macrophage degradation. Both density and electrophoretic mobility had virtually plateaued by 24 hours, but macrophage degradation was greater at 46 hours, suggesting that the changes in density and in biological properties are not linearly related.
It is important to note that the entire peak in the sucrose density gradient shifted to the right with only a slight broadening; therefore, the total population of particles, and not merely a subpopulation, demon- strated a greater buoyant density after exposure to endothelial cells. The EC-modified LDL also migrated as a single discrete band during agarose electrophoresis, indicating that enhanced electrophoretic mobility characterized the bulk of the conditioned LDL ( Figure 4 ). Therefore, most or all of the LDL molecules underwent some degree of modification even when the LDL concentration was as high as 200 /*g/ml. The magnitude of the density shift during short-term incubations was, in fact, inversely proportional to the LDL concentration. In some experiments in which LDL concentration was less than 50 pig/ml, the density of the LDL at the end of the incubation had increased to as much as 1.090 mg/ml.
In the experiments described thus far, aliquots of the LDL-containing medium that had been conditioned with endothelial cells were transferred to the cultures of macrophages without prior fractionation. To demonstrate that enhanced macrophage degradation of EC-modified LDL reflected a change in the EC-modified LDL itself rather than some effect of the conditioned medium on LDL degradation, EC-modified 125 I-LDL and control 12S I-LDL were repurified by preparative ultracentrifugation before testing their behavior in the macrophage culture system. As shown in Figure 5 , the re-isolated, EC-modified LDL was degraded three to four times more rapidly than control LDL, in good agreement with the previous results using unfractionated medium. 20 30 40
LDL CONCENTRATION (/^g protein/ml) The electrophoretic mobility of the conditioned LDL was determined using agarose electrophoresis. 25 The application sites are indicated by the arrow.
The possibility that some component or components released from cells into the medium might bring about the observed LDL modification was considered and 125 I-LDL was therefore incubated in cellfree medium that had been previously incubated with rabbit endothelial cells. Whereas this treatment failed to affect the density of the LDL or the rate of its subsequent degradation by macrophages, it did not rule out the possibility that LDL must be present with the cells to act as an acceptor or to evoke the release of cellular components. When LDL was incubated with endothelial cells at 4° C, no modification could be detected. Since many physical, as well as enzymatic, processes are much slower at this reduced temperature, the negative result is not conclusive.
To test whether there was a transfer of proteins from endothelial cells to LDL, the protein of EC-modified LDL was analyzed by SDS slab gel electrophoresis and compared with control LDL. No new polypeptides were detected in EC-modified LDL. Furthermore, the specific radioactivity of EC-modified 125 I-LDL (cpmVg protein) was not significantly different from that of control LDL, as also noted previously. 7 However, a small (less than 10%) 20 30 40 50 change in protein content would probably not have been detected. Since malondialdehyde-conjugated LDL, like ECmodified LDL, is taken up in part via the acetyl LDL receptor, two preparations of EC-modified LDL were analyzed by the method of Fogelman et al. 6 However, less than 1 mole of malondialdehyde per mole of apo B was found.
LDL CONCENTRATION protein/ml)
The rabbit endotheliai cell line used in most of these studies has been shown by Buonassisi and coworkers 9 to retain most of the characteristic properties of normal endotheliai cells, but these cells are heteroploid and it was important to test whether normal human endotheliai cells could effect the same modification of LDL. As demonstrated in Figure 6 A, conditioning of human 125 I-LDL with a primary culture of human umbilical vein endotheliai cells enhanced its subsequent degradation in macrophages to about the same extent as did conditioning with the established line of rabbit aortic endotheliai cells. Previously we have shown that acetylated LDL and EC-modified LDL prepared with rabbit endotheliai cells competed for degradation by macrophages. 7 As shown in Figure 6 B, acetylated LDL also competed with EC-modified LDL prepared using human umbilical vein endotheliai cells. However, LDL conditioned with the 11-BAEC strain of bovine aortic endotheliai cells obtained from Michael A. Gimbrone was not altered in terms of the rate of its catabolism by macrophages (data not shown).
The capacity of other cell types to mimic endotheliai cell modification of LDL was explored. LDL conditioned with fibroblasts was metabolized by macrophages at the same rate as control LDL ( Figure 5 ). On the other hand, LDL conditioned by incubation with smooth muscle cells was degraded more rapidly than control LDL, although the effect was less striking than in the case of EC-modified LDL. Conditioning LDL with guinea pig smooth muscle cells yielded a preparation that was degraded 50% to 100% faster than control LDL in macrophages (Figure 7) . A similar degree of enhancement was observed when LDL was conditioned with swine smooth muscle cells (data not shown).
While the degradation of EC-modified LDL by macrophages was enhanced, its degradation in oth- The medium was collected, diluted with fresh F-10 medium to obtain the indicated concentrations of the lipoproteins, and then transferred to guinea pig smooth muscle cell cultures. After 14 hours of Incubation, the amount of 125 I radioactivity in LDL degradation products in the medium of each culture was determined. Values represent the mean of duplicate incubations; the range was less than ± 10%. er cell types was reduced. As Figure 8 illustrates, degradation of endothelial cell-modified LDL by cultured smooth muscle cells was reduced by approximately 50% from the rate observed with control LDL. A similar reduction in the rate of degradation was observed in cultured skin flbroblasts.
The possible effects of conditioning with endothelial cells on the metabolism of other lipoprotein fractions was examined. As shown in Figure 9 , conditioning of HDL or VLDL with endothelial cells did not significantly affect the rate at which macrophages subsequently degraded these lipoproteins.
The increased uptake and degradation of ECmodified LDL by macrophages was accompanied by increases in total cell cholesterol content, an increased rate of intracellular esterification of cholesterol, and a decrease in endogenous cholesterol synthesis. As shown in Table 1 , there was a net increment in total cholesterol content in J774 macrophages and in mouse peritoneal macrophages incubated with EC-modified LDL compared to the values in cells incubated with control LDL. The stimulation of cholesterol esterification was demonstrated in J774 macrophages by measuring the rates of incorporation of 3 H-oleate into cellular cholesteryl esters. As shown in Figure 10 , this incorporation was enhanced fourfold in the presence of EC-modified LDL relative to that in the presence of control LDL. The inhibition of cholesterol synthesis by EC-modified LDL is demonstrated in Table 2 . Control LDL had a limited inhibitory effect, approximately 17% at 10 fig/ ml, whereas EC-modified LDL suppressed synthesis by about 50% at the same concentration, an effect comparable to that of acetylated LDL.
Discussion
These studies show that incubation of LDL with endothelial cells induces some change in its structure that results in recognition by macrophages and subsequent degradation at three to five times the rate for unmodified LDL. The increased rate of metabolism of EC-modified LDL was the direct result of some intrinsic change in the structure of the LDL molecule, as established by the present studies in which the LDL was re-isolated from the EC-condi- Monoiayer cultures of peritoneal macrophages of J774 cells were incubated for 24 hours in F-10 medium with or without the indicated lipoprotein (25 /xg/ml) or 10% serum. Values present indicate the total cell cholesterol content and, in parenthesis, the esterified cholesterol content.
'Determined using the ferric chloride method. tDetermined using the enzyme method. ND = not determined.
tioned culture medium before measurements of the degradation rate. The change could be effected by incubation of human LDL either with an established line of rabbit aortic endothelial cells or with primary cultures of human endothelial cells. Thus, EC-modified LDL can be prepared in an homologous system of human endothelial cells and human LDL as well as in a heterologous system of rabbit endothelial cells and human LDL. On the other hand, incubation of LDL with a single strain of bovine aortic endothelial cells failed to alter its subsequent metabolism in macrophages. Whether this reflects a species difference or a difference in the properties expressed by this particular strain of bovine cells remains to be determined. The uptake and degradation of EC-modified LDL by macrophages was predominantly via a high-affin- Monolayers of J774 macrophages were cultured 2 days in 5% newborn calf serum. Cultures were rinsed twice and reincubated in serum-free medium containing the Indicated lipoprotein. After 4 hours, 1-14 C acetate (56.8 mCi/ mmol) was added to each culture (final concentration, 0.106 mM). One hour later, cells were harvested and llpids extracted for thin layer chromatography and radloassay.
ity, saturable pathway that is shared at least to some extent by acetylated LDL (Figure 6 B and Reference 7) . Undoubtedly, the receptors involved in lipoprotein metabolism in the macrophage constitute a complex system. However, it is clear that at least a subset of the binding sites that recognize chemically acetylated LDL participated in the recognition and degradation of EC-modified LDL, as evidenced by competition between EC-modified LDL and acetylated LDL. In view of this, it was predicted that uptake of ECmodified LDL would be associated with the changes in macrophage cholesterol metabolism that are characteristic of receptor-mediated endocytosis of LDL, namely, inhibition of endogenous cholesterol synthesis, increase in cholesterol esterification and increase in total cellular cholesterol content. That prediction was borne out by the studies reported here.
LDL conditioned by incubation with either of two different lines of human skin fibroblasts showed little or no change in subsequent degradation rate in macrophages. However, the change induced by endothelial cells is not unique since definite but smaller increases in macrophage degradation were seen when LDL was conditioned by incubation with swine or guinea pig arterial smooth muscle cells. Further studies are needed to determine the range of cell types capable of inducing this effect. In contrast, the selectivity of the LDL-endothelial cell interaction with regard to lipoprotein species was clear: the rate of metabolism of neither VLDL nor HDL in macrophages was altered by prior incubation with endothelial cells.
Although LDL has been shown by several groups to be potentially toxic to cells, 23 " 25 it is unlikely that the endothelial cell-induced modification of LDL was caused by any cytotoxic effect of LDL. First, endothelial cells induced modification of LDL when the concentration of LDL in the medium (15 to 20 fig protein/ml) was too low to be cytotoxic. 25 ' M Second, nonconfluent, growing endothelial cells also induced modification of LDL within 4 to 6 hours without showing any retardation in growth rate, as monitored by the length of time needed to reach confluency following the removal of LDL (data not shown).
Several physical and chemical changes were shown to be associated with endothelial cell modification of LDL. These included an increase in electrophoretic mobility and an increase in buoyant density. It is unlikely that the endothelial cells were selectively depleting the lower density classes from the LDL in the medium, since endothelial cells exposed to LDL degraded only a small portion (0.2% to 0.4%) of the total LDL in the culture medium. Moreover, at least 90% to 95% of the initial 12S I-LDL protein was recovered as trichloroacetic acid-insoluble protein in the culture medium at the end of the conditioning period. As reported elsewhere, 27 EC-modified LDL repurified from the conditioning medium has been shown to have a marked reduction in cholesterol contentapproximately 50% -which is sufficient to explain most of the increase in density.
Several mechanisms could lead to the observed changes in LDL. Uptake and metabolism via a receptor-mediated pathway seems improbable because the endothelial cells process only a minute portion of the added LDL by this pathway. 10 Diacytosis, or retrograde endocytosis, is a possible mechanism that must be tested. This process would entail large quantities of LDL entering and exiting endothelial cells in vesicles. Some intracellular metabolism of the LDL (removal of lipids from the lipoprotein or acquisition of material by the lipoprotein) could occur without exposure to lysosomal hydrolases. However, it is difficult to clearly distinguish diacytosis experimentally from another process wherein adherence of LDL to the cell surface is followed by release of the lipoprotein into the culture medium without transport into the interior of the cell.
Other plausible mechanisms for modification include the acquisition or removal of LDL components at the cell surface or in the medium. Such a process could be mediated either by a passive transfer of molecules or by enzymatic reactions. How the changes in biochemical components occur and whether they have relevance for the biological change observed -namely, enhanced degradation by macrophages -are not known. Conceivably, a change in the conformation of the particle could be induced by changes in the lipid composition of the lipoprotein that would affect surface features including those recognized by cell receptors. The acquisition of carbohydrate in the form of glycosaminoglycans, glycolipid or oligosaccharide could also affect receptor interactions. It is possible that more than one biochemical change in the lipoprotein particle is effected during the conditioning period.
In addition to the chemical modifications of LDL cited above, there are other examples of modification of LDL that affect the subsequent cellular metabolism of the lipoprotein. Stein et al 28 have reported that acetylated LDL, which is in itself not recognized by smooth muscle cells, can be converted by incubation with macrophages to a form that increases cho-lesterol esterification and suppresses cholesterol synthesis in smooth muscle cells. Goldstein, Brown and co-workers 29 have previously reported that binding of polyanions to LDL can alter its interaction with macrophage surface receptors, raising the possibility that LDL entering the subendothelial space may be altered by this mechanism as well. Finally, it has been previously noted 30 that tryptic digestion of LDL markedly increases its uptake and degradation by receptor-negative fibroblasts. The fact that we have demonstrated a cell-induced modification of native LDL supports the idea that modified forms of LDL may have (patho)physiological significance in vivo.
The endothelial cell-induced modification could be of particular importance in arterial wall metabolism. At the present time, the manner in which the uptake of EC-modified LDL and storage of cholesterol in macrophages could affect the progression of atherosclerosis cannot be stated with certainty. Yet, if the LDL modification demonstrated here occurs in vivo, it could at least explain how macrophages in the arterial wall and in xanthomata accumulate cholesterol. Macrophages have a small number of receptors for native LDL, as shown for J774 cells in the present study and for monocyte-derived macrophages; 631 however, macrophages take up and degrade EC-modified LDL at much higher rates than native LDL at any given concentration. As LDL makes the obligatory traverse across or through the endothelial layer, it could undergo the endothelial cell-induced biological modification and therefore be preferentially taken up and degraded locally by macrophages in the subendothelial space. This would serve to deliver LDL cholesterol to the macrophage, potentially contributing to its conversion to a foam cell. Net accumulation of cholesterol in the intima could then occur when the influx of LDL into the arterial wall is greater than the clearance capacity of the macrophages present.
It should be pointed out that it is unlikely that any EC-modified LDL generated on the lumenal surface of the vascular endothelium (or returning to the plasma) would be found in the circulation at steady state. The Kupffer cells in the liver express the acetyl LDL receptor and would be expected to rapidly clear any EC-modified LDL molecules from the plasma. In preliminary studies we have in fact observed a very rapid plasma decay of EC-modified LDL injected intravenously into rats. It is further worthwhile to note that the endothelial cell-induced modification of LDL may have general significance; e.g., it might facilitate the removal of LDL from the extravascular space, especially in areas of inflammation.
